ACE2 and COVID-19: The current data all fit into a hypothesis that CoV-2 infection damages endothelial cells through CoV-2-S-caused pro-inflammatory responses; however, a crucial question has not been clearly addressed: does CoV-2-S need to engage ACE2 to harm the endothelial cells?